Not bragging.. but my guess was 10 cents. 16 cents is far...

Not bragging.. but my guess was 10 cents. 16 cents is far better. I think I bough my first batch of shares at these levels and waited for 10 years(?). Ms. Rathjen could generate the buzz and take the share price from teens to 74 cents at one stage. I kept faith. But I started having doubts after so many sub-par results but still did not let the shares go.

I guess nothing is left for another round of hype. Correct me if I am wrong. May be Ms. Rathjen will retire. I have seen so many biotech companies in US which are just vehicles for cushy jobs for top management and nice retirement. I thought Bionomics was different.

One question I have is why do they design their trials with such low n value(number of subjects) and try to cram in so many end points? That in itself is a defeatist attitude.